SHK, as an inhibitor of uridine 5-diphosphateglucuronosyltransferase, exerts toxic effects on liver tissues ( in vitro study demonstrated that shikonin has potent cytotoxicity against 15 types of cancer cells through mitochondrial dysfunction and can induce apoptosis
Mean T1/2 was 138.4 minutes for GLP-1 RA vs 95.0 minutes for placebo, with a pooled mean difference of 36.0 minutes (p 0.05)
Serious adverse events are rare and typically linked to underlying health conditions rather than the medication itself
This is particularly concerning for menopausal women, who are already at risk for muscle loss (sarcopenia) due to aging and lower estrogen
Licensed 503A compounding pharmaciesthe only source PlexusDx usesare permitted to compound these medications when there is clinical need and prescription authority from a licensed provider
In the 1990s and 2000s, further non-RCT studies in the elderly with or without dementia/AD and low B12 status have also mostly shown no benefit of B12 for cognitive function